About
Ken Herrmann has served on Aktis Oncology's board of directors since May 2024. Since 2016 he has been the Director and Chair of the Department of Nuclear Medicine at the Universitaetsmedizin Essen in Germany, and he was previously a tenured Associate Professor in the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles. He received an MD and Doctorate in Medicine from Humboldt Universitaet Berlin and an MBA from the University of Zurich.
Roles
Aktis Oncology, Inc.
Director · Current role
May 2024–present
University of California, Los Angeles
Associate Professor, Molecular and Medical Pharmacology (tenured)
2015 - June 2021
External Roles
Universitaetsmedizin Essen
Director and Chair, Department of Nuclear Medicine
2016 - present
Also at Aktis Oncology, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.